StonvexLoading…
StonvexStonvexStonvexCore line items from TSEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.57B | $1.44B | $1.42B | $1.68B |
Operating Income | $194.17M | $191.31M | $547.26M | $311.67M |
Net Income | $220.47M | $207.86M | $518.49M | $264.57M |
EPS (Diluted) | $1.94 | $1.85 | $4.66 | $2.39 |
Total Assets | $3.32B | $3.08B | $2.92B | $2.55B |
Total Liabilities | $417.71M | $440.31M | $491.48M | $659.07M |
Cash & Equivalents | $235.37M | $271.89M | $260.66M | $340.76M |
Free Cash Flow OCF − CapEx | $-48.94M | $12.53M | $232.06M | $163.42M |
Shares Outstanding | 112.53M | 111.55M | 110.83M | 109.95M |